about
Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.Inflammatory rheumatic disorders and bone.Nmp4/CIZ closes the parathyroid hormone anabolic window.Osteopenia: debates and dilemmas.Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Long-term safety concerns of antiresorptive therapy.
@ast
Long-term safety concerns of antiresorptive therapy.
@en
type
label
Long-term safety concerns of antiresorptive therapy.
@ast
Long-term safety concerns of antiresorptive therapy.
@en
prefLabel
Long-term safety concerns of antiresorptive therapy.
@ast
Long-term safety concerns of antiresorptive therapy.
@en
P2093
P2860
P1476
Long-term safety concerns of antiresorptive therapy.
@en
P2093
Jeffrey R Curtis
Kenneth G Saag
P2860
P304
387-400, vi
P356
10.1016/J.RDC.2011.08.001
P577
2011-08-01T00:00:00Z